"Die Sana Kliniken Lübeck sind einer der größten Anbieter medizinischer Akutversorgung im östlichen Schleswig-Holstein. Mit unseren knapp 1.000 Mitarbeiterinnen und Mitarbeitern versorgen wir unsere Patientinnen und Patienten rund um die Uhr. Als Krankenhaus der Lübecker stehen wir für eine enge Verzahnung von ambulanter und stationärer Medizin. Wir bieten eine hochqualitative wohnortnahe Versorgung mit zahlreichen Fachabteilungen und spezialisierten Zentren. Am Wochenende und an Feiertagen steht den Bürgerinnen und Bürgern die KVSH Anlaufpraxis in unserem Haus von 09.00 bis 19.00 Uhr zur Verfügung."

During the past decade, Sana Kliniken Luebeck conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sana Kliniken Luebeck" #1 sponsor was "Aeris Therapeutics" with 2 trials, followed by "German CLL Study Group" with 2 trials sponsored, "Medtronic Vascular" with 2 trials sponsored, "ReCor Medical, Inc." with 2 trials sponsored and "Cardiac Dimensions Pty Ltd" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sana Kliniken Luebeck" #1 collaborator was "B. Braun Melsungen AG" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Elisabethinen Hospital" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Medical University of Lublin" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Sana Kliniken Luebeck" are "Hypertension" (4 trials), "Vascular Diseases" (4 trials), "Cardiovascular Diseases" (3 trials), "Leukemia" (2 trials) and "Pulmonary Emphysema" (2 trials). Many other conditions were trialed in "Sana Kliniken Luebeck" in a lesser frequency.

Most popular intervention types in "Sana Kliniken Luebeck" are "Device" (7 trials), "Drug" (5 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "cyclophosphamide" (3 trials), "Symplicity Spyral™ multi-electrode renal denervation system" (2 trials), "fludarabine phosphate" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sana Kliniken Luebeck" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Sana Kliniken Luebeck". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sana Kliniken Luebeck, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sana Kliniken Luebeck, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".